| Primary |
| Breast Cancer |
62.4% |
| Breast Cancer Female |
9.4% |
| Hypertension |
6.1% |
| Breast Cancer Metastatic |
5.8% |
| Osteopenia |
1.8% |
| Diabetes Mellitus |
1.5% |
| Blood Cholesterol Increased |
1.3% |
| Breast Cancer Recurrent |
1.3% |
| Neoplasm Malignant |
1.3% |
| Depression |
1.2% |
| Osteoporosis |
1.1% |
| Ill-defined Disorder |
0.9% |
| Hypothyroidism |
0.9% |
| Pain |
0.9% |
| Nasopharyngitis |
0.8% |
| Glaucoma |
0.8% |
| Metastases To Bone |
0.8% |
| Asthma |
0.7% |
| Breast Disorder |
0.7% |
| Breast Cancer Male |
0.6% |
|
| Death |
19.9% |
| Disease Progression |
10.7% |
| Weight Increased |
7.5% |
| Arthralgia |
7.2% |
| Pain In Extremity |
4.8% |
| Weight Decreased |
4.2% |
| Alopecia |
4.1% |
| Vaginal Haemorrhage |
4.1% |
| Pulmonary Embolism |
3.6% |
| Nausea |
3.5% |
| Hepatic Function Abnormal |
3.3% |
| Myalgia |
3.3% |
| Pain |
3.3% |
| Paraesthesia |
3.2% |
| Cerebrovascular Accident |
3.0% |
| Interstitial Lung Disease |
3.0% |
| Dysphagia |
2.9% |
| Insomnia |
2.9% |
| Rash |
2.9% |
| Gamma-glutamyltransferase Increased |
2.7% |
|
| Secondary |
| Breast Cancer |
40.6% |
| Breast Cancer Metastatic |
14.5% |
| Product Used For Unknown Indication |
13.5% |
| Hypertension |
7.1% |
| Drug Use For Unknown Indication |
5.2% |
| Breast Cancer Female |
3.1% |
| Metastases To Bone |
2.9% |
| Pain |
1.8% |
| Blood Cholesterol Increased |
1.2% |
| Breast Cancer Male |
1.1% |
| Fibromyalgia |
1.1% |
| Ventricular Tachycardia |
1.1% |
| Cough |
1.0% |
| Diabetes Mellitus |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Autonomic Nervous System Imbalance |
0.9% |
| Dyspepsia |
0.9% |
| Breast Cancer Recurrent |
0.7% |
| Gastritis Prophylaxis |
0.7% |
| Hot Flush |
0.7% |
|
| Alopecia |
7.5% |
| Osteoporosis |
7.5% |
| Malignant Neoplasm Progression |
6.8% |
| Neoplasm Progression |
6.8% |
| Arthralgia |
6.0% |
| Pain In Extremity |
6.0% |
| Disease Progression |
5.3% |
| Weight Decreased |
5.3% |
| Weight Increased |
5.3% |
| Pain |
4.5% |
| Syncope |
4.5% |
| Thrombocytopenia |
4.5% |
| Atrial Fibrillation |
3.8% |
| Febrile Neutropenia |
3.8% |
| Myocardial Infarction |
3.8% |
| Neuropathy Peripheral |
3.8% |
| Osteonecrosis |
3.8% |
| Pulmonary Embolism |
3.8% |
| Tongue Neoplasm Malignant Stage Unspecified |
3.8% |
| Vomiting |
3.8% |
|
| Concomitant |
| Breast Cancer |
30.9% |
| Metastases To Bone |
17.3% |
| Breast Cancer Metastatic |
14.9% |
| Osteoporosis |
3.6% |
| Drug Use For Unknown Indication |
3.5% |
| Pain |
3.4% |
| Hypertension |
3.2% |
| Depression |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Anxiety |
2.8% |
| Breast Cancer Recurrent |
1.8% |
| Hormone Replacement Therapy |
1.6% |
| Premedication |
1.6% |
| Insomnia |
1.5% |
| Neoplasm Malignant |
1.5% |
| Multiple Myeloma |
1.3% |
| Breakthrough Pain |
1.3% |
| Prophylaxis |
1.2% |
| Breast Cancer Female |
1.2% |
| Metastases To Spine |
1.2% |
|
| Weight Decreased |
21.3% |
| Vomiting |
9.3% |
| Tooth Extraction |
8.2% |
| Osteonecrosis |
7.9% |
| Wound Drainage |
5.2% |
| Toothache |
4.5% |
| Osteonecrosis Of Jaw |
4.4% |
| Viral Infection |
4.2% |
| Wound Infection Staphylococcal |
4.2% |
| Weight Increased |
3.8% |
| Urinary Tract Infection |
3.5% |
| Pyrexia |
3.0% |
| Walking Aid User |
3.0% |
| Swelling |
2.8% |
| Wheezing |
2.8% |
| Wound Dehiscence |
2.6% |
| Breast Cancer |
2.4% |
| Diarrhoea |
2.3% |
| Tumour Marker Increased |
2.3% |
| Vision Blurred |
2.3% |
|
| Interacting |
| Breast Cancer |
64.9% |
| Hypertension |
7.8% |
| Breast Cancer Metastatic |
3.9% |
| Metastasis |
3.9% |
| Autoimmune Thyroiditis |
2.6% |
| Hyperuricaemia |
2.6% |
| Hypothyroidism |
2.6% |
| Anxiety |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Deep Vein Thrombosis |
1.3% |
| Menopause |
1.3% |
| Neoplasm |
1.3% |
| Neoplasm Malignant |
1.3% |
| Neoplasm Prophylaxis |
1.3% |
| Supplementation Therapy |
1.3% |
| Upper Respiratory Tract Infection |
1.3% |
|
| Weight Decreased |
33.3% |
| Hepatitis Toxic |
20.0% |
| Gastric Disorder |
6.7% |
| Hepatic Enzyme Increased |
6.7% |
| International Normalised Ratio Increased |
6.7% |
| Liver Function Test Abnormal |
6.7% |
| Osteonecrosis |
6.7% |
| Spinal Pain |
6.7% |
| Urinary Incontinence |
6.7% |
|
